Literature DB >> 16507236

The emerging role of MRI in the diagnosis and management of cardiomyopathies.

Carlos Eduardo Rochitte1, Eduardo Marinho Tassi, Afonso Akio Shiozaki.   

Abstract

Cardiac magnetic resonance (CMR) has emerged as an important tool for the evaluation of cardiomyopathies, providing highly accurate information on the macroscopic changes of cardiac morphology, function, and tissue composition. For myocardial tissue characterization, the technique of myocardial delayed enhancement is a potentially promising tool for diagnosis, management, and prognosis. Several CMR approaches are now available to better diagnose and prognosticate dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular disease, myocarditis, and other cardiomyopathies.

Entities:  

Mesh：

Year:  2006        PMID： 16507236     DOI： 10.1007/s11886-006-0010-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  70 in total

Review 1.  Chagas' heart disease.

Authors:  J A Marin Neto; M V Simões; A V Sarabanda
Journal:  Arq Bras Cardiol       Date:  1999-03       Impact factor: 2.000

2.  Relation between interstitial myocardial collagen and the degree of clinical impairment in Chagas' disease.

Authors:  C Mady; B M Ianni; E Arteaga; G S Montes; E G Caldini; G Andrade; M C Giorgi; P H Saldiva
Journal:  Am J Cardiol       Date:  1999-08-01       Impact factor: 2.778

3.  Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy.

Authors:  K C Wu; A W Heldman; J A Brinker; J M Hare; J A Lima
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

Review 4.  Idiopathic hemochromatosis.

Authors:  T B Kinney; S A Deluca
Journal:  Am Fam Physician       Date:  1991-09       Impact factor: 3.292

5.  Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy.

Authors:  R Fattori; G Rocchi; F Celletti; P Bertaccini; C Rapezzi; G Gavelli
Journal:  Am Heart J       Date:  1998-11       Impact factor: 4.749

6.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

8.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.

Authors:  Harikrishna Tandri; Manoj Saranathan; E Rene Rodriguez; Claudia Martinez; Chandra Bomma; Khurram Nasir; Boas Rosen; João A C Lima; Hugh Calkins; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

9.  Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy.

Authors:  Yasuo Amano; Shinichiro Kumita; Morimasa Takayama; Tatuso Kumazaki
Journal:  AJR Am J Roentgenol       Date:  2005-08       Impact factor: 3.959

10.  Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors:  K J Silverman; G M Hutchins; B H Bulkley
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690
View more
  13 in total

1.  MRI of nonischemic cardiomyopathy.

Authors:  David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2010-10       Impact factor: 3.959

2.  Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures.

Authors:  Troy J Badger; Marcos Daccarett; Nazem W Akoum; Yaw A Adjei-Poku; Nathan S Burgon; Thomas S Haslam; Saul Kalvaitis; Suman Kuppahally; Gaston Vergara; Lori McMullen; Paul A Anderson; Eugene Kholmovski; Rob S MacLeod; Nassir F Marrouche
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-03-24

3.  Association of Left Atrial Local Conduction Velocity With Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.

Authors:  Kotaro Fukumoto; Mohammadali Habibi; Esra Gucuk Ipek; Sohail Zahid; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; David Spragg; Hiroshi Ashikaga; Natalia Trayanova; Gordon F Tomaselli; John Rickard; Joseph E Marine; Ronald D Berger; Hugh Calkins; Saman Nazarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

Review 4.  The Role of Atrial Structural Remodeling in Atrial Fibrillation Ablation:An Imaging Point of View for Predicting Recurrence.

Authors:  Yasushi Akutsu; Kaoru Tanno; Youichi Kobayashi
Journal:  J Atr Fibrillation       Date:  2012-08-20

Review 5.  The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Transl Res       Date:  2009-11-07       Impact factor: 4.132

6.  Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Bi-Xi Chen; Hai-Qun Xing; Juan-Ni Gong; Xiao-Juan Guo; Xiao-Ying Xi; Yuan-Hua Yang; Li Huo; Min-Fu Yang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-15       Impact factor: 9.236

7.  Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry.

Authors:  Anja Wagner; Oliver Bruder; Steffen Schneider; Detlev Nothnagel; Peter Buser; Guillem Pons-Lado; Thorsten Dill; Vinzenz Hombach; Massimo Lombardi; Albert C van Rossum; Juerg Schwitter; Jochen Senges; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-05       Impact factor: 5.364

8.  Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.

Authors:  Afonso Akio Shiozaki; Tiago Senra; Edmundo Arteaga; Martino Martinelli Filho; Cristiane Guedes Pita; Luis Francisco R Ávila; José Rodrigues Parga Filho; Charles Mady; Roberto Kalil-Filho; David A Bluemke; Carlos Eduardo Rochitte
Journal:  J Cardiovasc Comput Tomogr       Date:  2013-05-11

9.  Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Robert S Oakes; Troy J Badger; Eugene G Kholmovski; Nazem Akoum; Nathan S Burgon; Eric N Fish; Joshua J E Blauer; Swati N Rao; Edward V R DiBella; Nathan M Segerson; Marcos Daccarett; Jessiciah Windfelder; Christopher J McGann; Dennis Parker; Rob S MacLeod; Nassir F Marrouche
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

Review 10.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.